-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...
More »SEARCH RESULT
Total Matching Records found : 288
Most small drug makers aren’t WHO-GMP certified -Priyanka Sharma
-Livemint.com The Centre has started an outreach programme for such SMEs operating in 10 locations Considering that only one-fifth of the small and medium manufacturers of bulk and API (active pharmaceutical ingredient) drugs have been certified under the World Health Organization’s good manufacturing practices, the Centre has launched an outreach programme to establish India as a best-in-class pharma hub, said an official in the know. “As of now, India has around 6,790 SMEs...
More »A new legislation that mirrors the old -Dinesh S Thakur and Prashant Reddy T
-The Hindu The New Drugs, Medical Devices and Cosmetics Bill is antiquated and needs to be revised The Union Health Ministry recently published a new draft Bill to replace the antiquated Drugs and Cosmetics Act, 1940. While we salute the Ministry for recognising the need for a new legislation, there is much to disagree with the new Bill. To begin with, although the Ministry has described it as being consistent with the...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »Parl Committee Asks Govt Why It Didn’t Use PSUs To Make COVID Drugs -Banjot Kaur
-TheWire.in * The Parliamentary standing committee on chemicals and fertilisers has produced a report highlighting gaps in the availability of COVID-19 drugs and devices during the pandemic. * The committee has asked the national government why PSUs didn’t receive licenses to make COVID drugs when private manufacturers did. * The MPs on the committee also spotlighted widespread irrational drug use in COVID-19 management, despite the existence of a standard treatment protocol. New Delhi: The...
More »
